Which people with Type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region

被引:37
作者
Guthrie, B. [1 ]
Emslie-Smith, A. [2 ]
Morris, A. D.
机构
[1] Univ Dundee, Community Hlth Sci, Dundee DD2 4BF, Scotland
[2] Arthurstone Med Ctr, Dundee, Scotland
关键词
All-or-nothing quality measures; cardiovascular disease risk factors; healthcare quality; Type 2 diabetes mellitus; UK; PRIMARY-CARE; QUALITY INDICATORS; ETHNIC DISPARITIES; PERFORMANCE; DEPRIVATION; PAY; SEX; ASSOCIATION; MANAGEMENT; IMPACT;
D O I
10.1111/j.1464-5491.2009.02837.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To measure quality of vascular risk factor measurement and control in people with Type 2 diabetes after comprehensive pay-for-performance implementation and to examine variation by patient and practice characteristics. Methods Multi-level regression analysis of 10 191 patients with Type 2 diabetes registered with 59 practices in the Tayside region. Quality measures examined were recording of glycated haemoglobin (HbA(1c)), blood pressure (BP), cholesterol and smoking status in the last 12 months; achievement of recommended intermediate outcome targets (HbA(1c)< 7.4%, BP < 140/80 mmHg, cholesterol < 5.0 mmol/l, not smoking); and simple and all-or-none composite measures. Results Ninety-five per cent of all recommended processes were received by patients, with 88% of patients receiving all four. Half of all intermediate outcomes targets were achieved, but only 16% of patients achieved all four targets. Process and outcome of care were consistently worse for 1523 (15.0%) patients aged < 55 years. HbA(1c) and BP targets were progressively less likely to be achieved as body mass index increased. Women were less likely to achieve cholesterol targets, but apart from smoking status, there were no associations with socio-economic status. Conclusion Under comprehensive pay-for-performance, process of care is remarkably reliable, but intermediate outcome control less so. Previously identified socio-economic variations in diabetes care have been largely eliminated, but gender inequality is persistent. Younger people were considerably less likely to achieve intermediate outcome targets. Mitigating increased vascular risk in younger patients with Type 2 diabetes presents major challenges for health services in the face of the evolving epidemics of obesity and diabetes.
引用
收藏
页码:1269 / 1276
页数:8
相关论文
共 31 条
  • [21] Ethnic disparities in diabetes management and pay-for-performance in the UK: The Wandsworth prospective diabetes study
    Millett, Christopher
    Gray, Jeremy
    Saxena, Sonia
    Netuveli, Gopalakrishnan
    Khunti, Kamlesh
    Majeed, Azeem
    [J]. PLOS MEDICINE, 2007, 4 (06) : 1087 - 1093
  • [22] Impact of Pay for Performance on Ethnic Disparities in Intermediate Outcomes for Diabetes: A Longitudinal Study
    Millett, Christopher
    Netuveli, Gopalakrishnan
    Saxena, Sonia
    Majeed, Azeem
    [J]. DIABETES CARE, 2009, 32 (03) : 404 - 409
  • [23] MORRIS AD, 1997, BRIT MED J, V315, P528
  • [24] All-or-none measurement raises the bar on performance
    Nolan, T
    Berwick, DM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (10): : 1168 - 1170
  • [25] Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    Patel, Anushka
    MacMahon, Stephen
    Chalmers, John
    Neal, Bruce
    Billot, Laurent
    Woodward, Mark
    Marre, Michel
    Cooper, Mark
    Glasziou, Paul
    Grobbee, Diederick
    Hamet, Pavel
    Harrap, Stephen
    Heller, Simon
    Liu, Lisheng
    Mancia, Giuseppe
    Mogensen, Carl Erik
    Pan, Changyu
    Poulter, Neil
    Rodgers, Anthony
    Williams, Bryan
    Bompoint, Severine
    de Galan, Bastiaan E.
    Joshi, Rohina
    Travert, Florence
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) : 2560 - 2572
  • [26] *SCOTT EX, 2007, SCOTT DIAB SURV 2005
  • [27] *SCOTT EX HLTH DEP, 2004, REV SCOTT DIAB FRAM
  • [28] *SCOTT INT GUID NE, 2006, SIGN DIAB GUID
  • [29] *SCOTT INT GUID NE, 2007, SIGN 97 RISK EST PRE
  • [30] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853